Charles River Laboratories Announces First-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Charles River Laboratories (CRL) Tops Q1 EPS by 37c, Updates Guidance
May 7, 2020 7:12 AM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $1.84, $0.37 better than the analyst estimate of $1.47. Revenue for the quarter came in at $707.1 million versus the consensus estimate of $691.09 million.
GUIDANCE:
Charles River Laboratories sees FY2020 EPS of $6.75-$7.10, versus the... More
